Suppr超能文献

生物心室辅助装置的研发:来自小动物模型的初步数据。

Development of a biological ventricular assist device: preliminary data from a small animal model.

作者信息

Yildirim Yalin, Naito Hiroshi, Didié Michael, Karikkineth Bijoy Chandapillai, Biermann Daniel, Eschenhagen Thomas, Zimmermann Wolfram-Hubertus

机构信息

Institute of Experimental and Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.

出版信息

Circulation. 2007 Sep 11;116(11 Suppl):I16-23. doi: 10.1161/CIRCULATIONAHA.106.679688.

Abstract

BACKGROUND

Engineered heart tissue (EHT) can be generated from cardiomyocytes and extracellular matrix proteins and used to repair local heart muscle defects in vivo. Here, we hypothesized that pouch-like heart muscle constructs can be generated by using a novel EHT-casting technology and applied as heart-embracing cardiac grafts in vivo.

METHODS AND RESULTS

Pouch-like EHTs (inner/outer diameter: 10/12 mm) can be generated mainly from neonatal rat heart cells, collagen type I, and serum containing culture medium. They contain a dense network of connexin 43 interconnected cardiomyocytes and an endo-/epicardial surface lining composed of prolylhydroxylase positive cells. Pouch-like EHTs beat spontaneously and show contractile properties of native heart muscle including positive inotropic responses to calcium and isoprenaline. First implantation studies indicate that pouch-like EHTs can be slipped over uninjured adult rat hearts to completely cover the left and right ventricles. Fourteen days after implantation, EHT-grafts stably covered the epicardial surface of the respective hearts. Engrafted EHTs were composed of matrix and differentiated cardiac muscle as well as newly formed vessels which were partly donor-derived.

CONCLUSIONS

Pouch-like EHTs can be generated with structural and functional properties of native myocardium. Implantation studies demonstrated their applicability as cardiac muscle grafts, setting the stage for an evaluation of EHT-pouches as biological ventricular assist devices in vivo.

摘要

背景

工程化心肌组织(EHT)可由心肌细胞和细胞外基质蛋白生成,并用于修复体内局部心肌缺损。在此,我们假设可以通过一种新型的EHT铸造技术生成袋状心肌构建体,并将其作为环抱心脏的心脏移植物应用于体内。

方法与结果

袋状EHT(内径/外径:10/12毫米)主要可由新生大鼠心脏细胞、I型胶原蛋白和含血清培养基生成。它们包含由连接蛋白43相互连接的心肌细胞组成的致密网络,以及由脯氨酰羟化酶阳性细胞构成的内膜/外膜表面衬里。袋状EHT能自发搏动,并表现出天然心肌的收缩特性,包括对钙和异丙肾上腺素的正性肌力反应。首次植入研究表明,袋状EHT可以套在未受伤的成年大鼠心脏上,完全覆盖左心室和右心室。植入后14天,EHT移植物稳定地覆盖了相应心脏的外膜表面。植入的EHT由基质、分化的心肌以及部分源自供体的新形成血管组成。

结论

可以生成具有天然心肌结构和功能特性的袋状EHT。植入研究证明了它们作为心肌移植物的适用性,为评估EHT袋作为体内生物心室辅助装置奠定了基础。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验